Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$8.94B
| $2.08M | ﹤0.01% |
63,400
+48,100
| +314% | +$1.58M |
|
|
AFCG
1927
AFC Gamma
AFCG
$99.6M
| $2.07M | ﹤0.01% |
251,876
+70,993
| +39% | +$585K |
|
|
YSG
1928
Yatsen Holding
YSG
$908M
| $2.07M | ﹤0.01% |
566,149
-6,920
| -1% | -$25.3K |
|
1929
Benchmark Electronics
BHE
$1.43B
| $2.07M | ﹤0.01% |
74,800
-39,950
| -35% | -$1.1M |
|
1930
abrdn Physical Gold Shares ETF
SGOL
$5.94B
| $2.07M | ﹤0.01% |
+104,598
| New | +$2.07M |
|
1931
Franklin FTSE Japan ETF
FLJP
$2.4B
| $2.06M | ﹤0.01% |
+73,700
| New | +$2.06M |
|
1932
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11.4B
| $2.06M | ﹤0.01% |
35,300
+16,800
| +91% | +$982K |
|
1933
CytomX Therapeutics
CTMX
$330M
| $2.06M | ﹤0.01% |
1,325,700
+395,600
| +43% | +$613K |
|
1934
Avidity Biosciences
RNA
$5.41B
| $2.05M | ﹤0.01% |
226,700
+115,900
| +105% | +$1.05M |
|
1935
Rackspace Technology
RXT
$326M
| $2.05M | ﹤0.01% |
1,025,600
-490,234
| -32% | -$980K |
|
1936
Nokia
NOK
$25.4B
| $2.05M | ﹤0.01% |
599,400
-5,226,200
| -90% | -$17.9M |
|
1937
AnaptysBio
ANAB
$566M
| $2.05M | ﹤0.01% |
95,600
+2,900
| +3% | +$62.1K |
|
1938
Valhi
VHI
$462M
| $2.05M | ﹤0.01% |
134,717
-2,500
| -2% | -$38K |
|
|
API
1939
Agora
API
$347M
| $2.04M | ﹤0.01% |
777,100
-5,800
| -0.7% | -$15.3K |
|
|
MITT
1940
AG Mortgage Investment Trust
MITT
$251M
| $2.04M | ﹤0.01% |
321,640
+141,540
| +79% | +$899K |
|
|
SILK
1941
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $2.04M | ﹤0.01% |
166,300
-41,300
| -20% | -$507K |
|
1942
Avantis US Equity ETF
AVUS
$9.66B
| $2.04M | ﹤0.01% |
25,000
+12,700
| +103% | +$1.04M |
|
1943
Republic Bancorp
RBCAA
$1.48B
| $2.04M | ﹤0.01% |
36,900
-4,200
| -10% | -$232K |
|
1944
Boston Omaha
BOC
$424M
| $2.03M | ﹤0.01% |
129,062
-49,438
| -28% | -$778K |
|
|
CHMI
1945
Cherry Hill Mortgage Investment Corp
CHMI
$94.8M
| $2.03M | ﹤0.01% |
502,584
+2,700
| +0.5% | +$10.9K |
|
1946
iShares ESG Aware MSCI EM ETF
ESGE
$5.45B
| $2.03M | ﹤0.01% |
63,300
-3,500
| -5% | -$112K |
|
1947
i3 Verticals
IIIV
$729M
| $2.03M | ﹤0.01% |
95,800
+27,673
| +41% | +$586K |
|
1948
Liberty Broadband Class A
LBRDA
$8.94B
| $2.02M | ﹤0.01% |
+25,100
| New | +$2.02M |
|
1949
Nice
NICE
$9.2B
| $2.02M | ﹤0.01% |
10,144
-39,900
| -80% | -$7.96M |
|
1950
Alto Ingredients
ALTO
$92.9M
| $2.01M | ﹤0.01% |
755,000
+103,300
| +16% | +$275K |
|